In Pakistan, a pharmaceutical company is planning to import the antiviral drug remdesivir from Bangladesh. The drug is used to treat the coronavirus patients.
Searle Company Limited made this announcement a day after 56 deaths from the virus were recorded in the country in a single day.
As per the firm, it has entered into an exclusive licensing and marketing agreement with Bangladesh’s Beximco Pharmaceuticals which is the first company in the world to introduce the generic variant of the drug.
The company told the Pakistan Stock Exchange, “Searle Pharma is planning to import remdesivir in finished form ready to use) to meet the country’s urgent requirements.”
A drug developed by Gilead Sciences Remdesivir attracted attention as one of the most effective treatments for COVID-19.
Earlier in May, Ferozson’s Pharma declared that it would make the drug in Pakistan after signing a non-exclusive licensing pact with Gilead. The companyy aims to make and sell the drug to 127 nations. But it did warn that the production can take “weeks”.
As per Searle, Bangladesh imports will make sure an immediate supply of the drug at an affordable price. It will help in eliminating treatment delays by healthcare providers in Pakistan.